Skip to main content
OpenTrials
Completed

NCT Number: NCT02213120

To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.

The VERTIGO study is likely to help determine characteristics of different types of vertigo in patients presenting in the Ear Nose & Throat (ENT) clinics with complaints of dizziness. Moreover, it will also help to develop an understanding about the current management practices of this condition at local level.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vertigo Dizziness Ear Diseases Labyrinth Diseases Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Vestibular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research facility ID ORG-001139, Hyderābād, Pakistan

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patients 18 years of age and older
  • Patients with vestibular vertigo of known or unknown origin
  • Patients who are willing and able to provide written informed consent

Exclusion criteria

  • Patients with any condition which, in the opinion of the investigator, makes the patient unsuitable for inclusion based on clinical judgment
  • Patient with psychiatric disorders, significant neurological disorder or spinal cord damage that would make the evaluation difficult for the investigator
  • Patients who are not willing to give informed consent
  • Patients with a known history of hypersensitivity to betahistine
  • Patients with a history of pheochromocytoma

Treatment and study plan

Primary outcomes

  1. Characteristics (Different Types) of dizziness

    Time frame: 6 months

    It will be determined that a patient with dizziness is suffering from what type of Vertigo i.e. Benign Paroxysmal Positional Vertigo, Menier's Disease, Vestibular Neuritis, Labyrinthitis or any other. As these are clinical types of Vertigo these cannot be measured in units

Secondary outcomes

  1. Quality of Life (QoL) of patients at baselines

    Time frame: 6 months

    Dizziness Handicap Inventory will be used

  2. Management of vertigo currently in practice

    Time frame: 6 months

    As per practice of the physician/Investigator. Management of Vertigo is either by certain maneuvers such as Epley's and Simont or by medications. For the maneuvers, no unit can be defined. The information for medication which will be collected will be Name (preferably the generic name), Dose, Units (form of the medicine), Route and Frequency.

  3. QoL of patients post treatment

    Time frame: 6 months

    Dizziness Handicap Inventory will be used

Sponsors and collaborators

Lead sponsor

Abbott

Industry

Collaborators

  • Dimension Research

Registry information

Official study title

To Study the Characteristics of Different Types of Vertigo in Patients Attending the ENT Clinics.

Acronym: VERTIGO

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Aug 11, 2014
Registry last updated
May 28, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.